The global mHealth market size reached US$ 73.9 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 263.4 Billion by 2028, exhibiting a growth rate (CAGR) of 23.6% during 2022-2028.

Mobile health (mHealth) is a diversified branch of electronic health (eHealth) that collects patient data using mobile devices and wireless infrastructure. The collected data assists in obtaining accurate results that are utilized to treat and diagnose several medical conditions. mHealth assists in improving medication adherence and communication, allows remote patient monitoring and enables patients to send secure messages, connect to service providers and schedule appointments. As a result, it finds extensive application in healthcare supply chain management, diagnostic and treatment support, chronic disease monitoring and management and increasing health awareness among people. At present, mHealth technology is gaining popularity across the globe for home-based patient monitoring services among the geriatric population.

The rising dependence on mobile devices represents one of the key factors strengthening the global mHealth market growth. These devices enable individuals to access healthcare-related services via wireless multimedia easily. Moreover, mHealth solutions have user-friendly characteristics and offer efficiency during an emergency. This, in confluence with the increasing instances of chronic diseases, such as diabetes and hypertension, is positively influencing the market growth worldwide. Furthermore, the key manufacturers are integrating innovative technologies to support the healthcare industry, which, in turn, is fostering the market growth. For instance, the US Food and Drug Administration (FDA) announced the launch of an internet-based repository, CURE ID, in December 2019 that enabled the clinical community to report their experiences of treating infectious diseases with the existing FDA-approved drugs through smartphones, websites or other mobile devices.

Key Market Segmentation:
IMARC Group provides an analysis of the key trends in each sub-segment of the global mHealth market report, along with forecasts at the global, regional and country level from 2023-2028. Our report has categorized the market based on component, service and participants.

Breakup by Component:

Wearables
Blood Pressure Monitors
Blood Glucometer
Pulse Oximeter
Neurological Monitors
Others
mHealth Apps
Medical Apps
Fitness Apps

Breakup by Service:

Monitoring Services
Diagnosis Services
Healthcare Systems Strengthening Services
Treatment Services
Others

Breakup by Participants:

mHealth Application Companies
Pharmaceuticals Companies
Hospitals
Health Insurance Companies
Others

Breakup by Region:

North America
United States
Canada
Asia-Pacific
China
Japan
India
South Korea
Australia
Indonesia
Others
Europe
Germany
France
United Kingdom
Italy
Spain
Russia
Others
Latin America
Brazil
Mexico
Others
Middle East and Africa

Competitive Landscape:
The competitive landscape of the industry has also been examined along with the profiles of the key players being Airstrip Technologies Inc., Allscripts Healthcare Solutions Inc., Apple Inc., Bayer Aktiengesellschaft, Boston Scientific Corporation, Koninklijke Philips N.V., Masimo Corporation, Omron HealthCare Inc. (OMRON Corporation), Qualcomm Incorporated, Samsung Electronics Co. Ltd. and Sanofi S.A.

Key questions answered in this report:
How has the global mHealth market performed so far and how will it perform in the coming years?
What has been the impact of COVID-19 on the global mHealth market?
What are the key regional markets?
What is the breakup of the market based on the component?
What is the breakup of the market based on the service?
What is the breakup of the market based on the participants?
What are the various stages in the value chain of the industry?
What are the key driving factors and challenges in the industry?
What is the structure of the global mHealth market and who are the key players?
What is the degree of competition in the industry?